Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $11.52 and last traded at $11.40, with a volume of 395431 shares changing hands. The stock had previously closed at $9.94.
Cybin Trading Down 5.4 %
The stock has a market cap of $1.60 billion and a P/E ratio of -44.92. The company’s fifty day simple moving average is $7.20 and its 200-day simple moving average is $2.70.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- How to Invest in the Best Canadian Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- How Can Investors Benefit From After-Hours Trading
- MarketBeat Week in Review – 11/4 – 11/8
- Compound Interest and Why It Matters When Investing
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
